Therapeutic Value of Drugs Frequently Marketed Using Direct-to-Consumer Television Advertising, 2015 to 2021

JAMA Netw Open. 2023 Jan 3;6(1):e2250991. doi: 10.1001/jamanetworkopen.2022.50991.

Neeraj G Patel^{1

2}, Thomas J Hwang¹, Steven Woloshin^{3

4}, Aaron S Kesselheim¹

¹ Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
² Yale School of Medicine, New Haven, Connecticut.
³ Center for Medicine in the Media, Dartmouth Institute for Health Policy and Clinical Practice, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire.
⁴ Lisa Schwartz Foundation for Truth in Medicine, Norwich, Vermont.

No abstract available

Plain language summary

This cohort study assesses whether drugs with the most direct-to-consumer television advertising represent advances over existing treatments.